Literature DB >> 3399713

[Splenic irradiation in the treatment of idiopathic myelofibrosis. Retrospective study of 14 cases].

R Sciascia1, P Mazza, L Tondi.   

Abstract

A retrospective study was conducted on 14 patients with idiopathic myelofibrosis after splenic irradiation in order to cure the symptoms due to secondary splenomegaly. Radiation dose ranged from 700 to 2400 cGy, depending on both clinical response and hematological toxicity. Relief of symptoms was observed in all patients (100%); reduction of splenic size ranged from 30 to 70%, with more than 50% reduction in 13/16 cases. Side effects were mild neutropenia and thrombocytopenia, which did not require interruption of treatment; four patients registered a severe anemia. All the hematological side effects stopped with the suspension of treatment. This study shows the beneficial effect of radiation therapy on the symptoms connected to splenomegaly; however, the short duration of response suggests the advantage of splenic low-dose irradiation, to be periodically repeated.

Entities:  

Mesh:

Year:  1988        PMID: 3399713

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  2 in total

1.  Palliative splenic irradiation for symptomatic splenomegaly in non-Hodgkin lymphoma.

Authors:  Liliana Castro Oliveira; Carlos Fardilha; Manuel Louro; Carlos Pinheiro; Abílio Sousa; Herlander Marques; Paulo Costa
Journal:  Ecancermedicalscience       Date:  2018-12-13

2.  Treatment of symptomatic splenomegaly with low doses of radiotherapy: Retrospective analysis and review of the literature.

Authors:  Carolina de la Pinta; Eva Fernández Lizarbe; Ángel Montero Luis; José Antonio Domínguez Rullán; Sonsoles Sancho García
Journal:  Tech Innov Patient Support Radiat Oncol       Date:  2017-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.